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Background:  Despite outcome improvement re-hospitalization of congestive heart failure (CHF) is high. Sleep disordered breathing 
(SDB) is common and under-diagnosed in CHF patients. We hypothesized that early recognition and treatment of SDB in hospitalized CHF 
patients will reduce hospital visits (combined end point of Emergency room visits and hospital readmissions).
methods:  Patients admitted for CHF underwent overnight polysomnography within 4 weeks of discharge. Patients diagnosed with SDB 
were advised therapy with positive airway pressure (PAP) therapy and dichotomized into compliant versus non compliant group. Hospital 
admissions for 6 months before therapy were compared with readmission within 6 months post therapy. Compliance was monitored 
objectively with data from the device.
results:  A total of 64 patients were diagnosed with SDB post discharge. Compliance data was available on 59 patients. Of the 59 patients, 
29 (49%) were complaint with PAP therapy. The mean age of this cohort of patients was 60.4 years (range 30-86), BMI was 38.2 kg/m2 
(18-55.4), 47.5 % were males , 52.5% were African Americans with mean AHI of 33.1 (4.1-112.7). The compliant group had 36 hospital 
visits six months prior to therapy, which reduced to 17 visits within six months post therapy. In the non- compliant group there were a total 
of 39 visits before therapy and increased to 45 events post therapy. The mean change in hospital visits decreased to -0.7 ± 1.8 visits for the 
compliant group compared to a mean increase of 0.2 ± 1.8 visits for the non-compliant group (paired Wilcoxon test, p=0.03). Pulmonary 
artery systolic pressure (PASP) as measured by echocardiogram was significantly reduced in the compliant group post therapy. The mean 
change in PASP between prior and post therapy decreased to -4.3 ± 13.9 for the compliant group compared to a mean increase of 11.9 ± 
10.7 for the non-compliant group (paired Wilcoxon test, p=0.02).
conclusion:  This study suggests that patients admitted with decompensated CHF with SDB and complaint with PAP therapy have 
reduction in 6 months hospital visits post therapy.
